Moreover, a comparison between fluoxetine monotherapy and combination therapy with high-dose atorvastatin (80 mg/day) demonstrated a reduction in pro-inflammatory cytokines and other pro-inflammatory cytokines and other inflammatory markers such as NLRP-3 and IL-6, as well as improved Hamilton Depression Rating Scale scores (150). Here, IL6 is linked to depressive symptom measurement.